For BRCA1/2 mutation carriers not only infertility, but also oncologic treatment strategies affecting fertility and/or risk-reducing salpingo-oophorectomy direct female mutation carriers to ovarian stimulation for IVF for fertility preservation.10,11 In addition, during the past decade the request for preimplantation genetic diagnosis (PGD) has increased rapidly for BRCA1/2 mutation carriers, i.e., genetic testing of embryos for the presence of a known familial mutation before transfer in order to establish a pregnancy of a foetus without the genetic condition.12–14. The gene discussed is BRCA1; the disease is Infertility.